Pharmacology, Toxicology and Pharmaceutical Science
Disease
96%
Cohort Study
83%
Treatment Resistant Depression
55%
Case-Control Study
31%
Hydroxysteroid Dehydrogenase
27%
Prescription Drug
27%
Methyltransferase
27%
Subcutaneous Injection
27%
Immunoglobulin
27%
Polyradiculoneuropathy
27%
Infection
27%
5,10 Methylenetetrahydrofolate Reductase (FADH2)
27%
Catechol
27%
Onset Age
27%
Cortisone
27%
Psychotrauma
27%
Hydrocortisone
27%
Intravenous Therapy
27%
Autoimmune Disease
27%
Complement Component C3
27%
Complement Component C4
27%
Prematurity
17%
Sodium Chloride
13%
Life Expectancy
9%
Antidepressant
8%
Organic Psychosyndrome
6%
Side Effect
6%
Psychotropic Agent
6%
Mortality
6%
Eating Disorder
5%
Complement
5%
Neuroscience
Dementia Praecox
100%
Pervasive Developmental Disorder
36%
Treatment-Resistant Depression
27%
Intravenous Immunoglobulin
27%
Methyltransferase
27%
Mental Disorder
27%
5,10 Methylenetetrahydrofolate Reductase (FADH2)
27%
Psychotrauma
27%
Single-Nucleotide Polymorphism
27%
Attention Deficit Hyperactivity Disorder
23%
Paternity
13%
Mood Disorder
9%
Germ Cell
6%
Exome Sequencing
6%
Gene Mutation
6%
Antidepressant
6%
Complement
5%
Medicine and Dentistry
Methylenetetrahydrofolate Reductase
27%
Immunoglobulin
27%
Intravenous Drug Administration
27%
Polyradiculoneuropathy
27%
Complement Component C3
27%
Complement Component C4
27%
Subcutaneous Injection
27%
Psychotrauma
27%
Methyltransferase
27%
Autoimmune Disease
27%
Sodium Chloride
13%
Muscle Strength
13%
Mental Disorder
11%
Genome Wide Association Study
11%
Mendelian Randomization Analysis
11%
Injection Site
6%
Maintenance Therapy
6%
Medical Research
6%
Allele
6%
Walk Test
6%
Side Effect
6%
Post-Hoc Analysis
5%
Complement
5%
Neonate
5%
Phenome
5%
